Best Low Price Stocks To Invest In 2019

If you are an income investor looking at gold stocks you might be tempted to buy Wheaton Precious Metals (NYSE:WPM), a gold and silver streaming company with a relatively high yield. It’s not a bad stock to own, but it may not be the best dividend stock for your portfolio if you don’t understand a few important basics. Here’s what you need to know before you buy Wheaton for its peer-beating dividend yield.

What Wheaton does

The first thing to understand is that Wheaton Precious Metals is not a miner. It is a streaming company. That means it provides cash up front to miners in exchange for the right to buy gold and silver at reduced rates in the future. It’s a business model that provides Wheaton with wide margins in both good markets and bad because of its contractually locked-in low prices.

Image source: Getty Images

Best Low Price Stocks To Invest In 2019: Cyclacel Pharmaceuticals Inc.(CYCC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Investment analysts at Roth Capital assumed coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC) in a research note issued to investors on Wednesday, The Fly reports. The firm set a “buy” rating and a $8.00 price target on the biotechnology company’s stock. Roth Capital’s price objective would suggest a potential upside of 459.44% from the company’s current price.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Cyclacel Pharmaceuticals (CYCC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Cyclacel Pharmaceuticals (NASDAQ:CYCC) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “CYCLACEL is a biopharmaceutical company dedicated to the discovery, development and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders. Three orally-available Cyclacel drugs are in clinical development. Sapacitabine, a cell cycle modulating nucleoside analog, is in Phase 2 studies for the treatment of acute myeloid leukemia in the elderly, myelodysplastic syndromes and cutaneous T-cell lymphoma. Seliciclib (CYC202 or R-roscovitine), a CDK inhibitor, is in Phase 2 for the treatment of lung cancer and nasopharyngeal cancer. “

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Cyclacel Pharmaceuticals (CYCC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    ILLEGAL ACTIVITY WARNING: “Cyclacel Pharmaceuticals (CYCC) Sees Unusually-High Trading Volume” was originally posted by Ticker Report and is owned by of Ticker Report. If you are viewing this report on another publication, it was stolen and republished in violation of U.S. and international trademark & copyright laws. The correct version of this report can be read at www.tickerreport.com/banking-finance/4199574/cyclacel-pharmaceuticals-cycc-sees-unusually-high-trading-volume.html.

  • [By Ethan Ryder]

    Shares of Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shot up 7.5% during trading on Friday . The stock traded as high as $0.90 and last traded at $0.86. 1,753,743 shares traded hands during mid-day trading, an increase of 258% from the average session volume of 489,758 shares. The stock had previously closed at $0.80.

Best Low Price Stocks To Invest In 2019: Regis Corporation(RGS)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market continued moving up on Tuesday, with the S&P 500 hitting a new high at points during the session before pulling back slightly. Even though the Dow Jones Industrial Average is still well short of its record levels, market participants were pleased to see extremely strong sentiment from investors, especially among stocks of smaller companies. With the current bull market being well into its 10th year, many skeptics have looked for signs of eroding confidence, but those that have appeared recently haven’t had any lasting downward impact on stocks. Good news from several companies helped contribute to the positive mood on Wall Street. Cronos Group (NASDAQ:CRON), Medtronic (NYSE:MDT), and Regis (NYSE:RGS) were among the best performers on the day. Here’s why they did so well.

  • [By Motley Fool Transcribing]

    Regis (NYSE:RGS) Q4 2018 Earnings Conference CallAug. 21, 2018 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    Shares of Regis Co. (NYSE:RGS) have been given an average rating of “Buy” by the six ratings firms that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $18.00.

  • [By Shane Hupp]

    Carriage Services (NYSE: CSV) and Regis (NYSE:RGS) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation and institutional ownership.

  • [By Ethan Ryder]

    Regis Co. (NYSE:RGS) shares saw an uptick in trading volume on Wednesday following a stronger than expected earnings report. 45,591 shares were traded during trading, a decline of 65% from the previous session’s volume of 129,424 shares.The stock last traded at $21.56 and had previously closed at $20.86.

  • [By Max Byerly]

    JPMorgan Chase & Co. reduced its position in shares of Regis Co. (NYSE:RGS) by 4.0% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,065,983 shares of the company’s stock after selling 44,497 shares during the quarter. JPMorgan Chase & Co. owned about 2.31% of Regis worth $16,128,000 as of its most recent SEC filing.

Best Low Price Stocks To Invest In 2019: Loews Corporation(L)

Advisors’ Opinion:

  • [By Logan Wallace]

    ValuEngine cut shares of Loews (NYSE:L) from a buy rating to a hold rating in a report published on Friday morning.

    L has been the topic of several other reports. Zacks Investment Research cut shares of Loews from a hold rating to a sell rating in a research report on Tuesday, May 1st. Citigroup raised shares of Loews from a neutral rating to a buy rating and cut their price objective for the company from $63.10 to $30.70 in a research report on Monday, May 14th. Finally, Desjardins cut shares of Loews to a hold rating and set a $76.00 price objective on the stock. in a research report on Tuesday, January 30th. Three equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company. The company currently has a consensus rating of Hold and a consensus target price of $49.68.

  • [By Dan Caplinger]

    Finally, units of Boardwalk Pipeline Partners rose 5%. The master limited partnership has seen its value consistently erode over the past year, but there’s been speculation in the last several months that controlling shareholder Loews (NYSE:L) could choose to buy out the limited partnership units. Some investors have been pleased at the idea of possibly getting a quick bump from recent low share prices, but longer-term unitholders aren’t thrilled about having held on this long only to have Loews buy them out at a bargain price. It’s unclear which side will win out, but today’s move at least makes it clear that investors are paying attention.

  • [By Joseph Griffin]

    PNC Financial Services Group Inc. cut its holdings in shares of Loews Co. (NYSE:L) by 19.8% in the 2nd quarter, Holdings Channel reports. The firm owned 15,330 shares of the insurance provider’s stock after selling 3,776 shares during the period. PNC Financial Services Group Inc.’s holdings in Loews were worth $742,000 at the end of the most recent reporting period.

Leave a Reply

Your email address will not be published. Required fields are marked *